(Reuters) - Johnson & Johnson said it would pay up to $1 billion for Aragon Pharmaceuticals and its experimental drugs for prostate cancer, bolstering J&J's role in the field after ...
Read more
(Reuters) - Johnson & Johnson is voluntarily recalling about 32 million packages of its birth control pill Cilest in Europe, Asia and Latin America, a spokeswoman said late on Tuesday, ...
Read more
Novocure Ltd. may be the most successful Israeli life sciences company which you have never heard of. The company, which has taken care to stay below the radar, has developed ...
Read more
May 23 (Reuters) - Johnson & Johnson said on Thursday that it plans to submit more than 10 new products for regulatory approval by 2017, including drugs to treat hepatitis ...
Read more
(Reuters) - The Food and Drug Administration has approved Johnson & Johnson's drug Simponi for patients with moderate to severe ulcerative colitis, an inflammatory disease affecting the colon.Simponi is already ...
Read more
(Reuters) - U.S. regulators have approved Johnson & Johnson's Sedasys system to sedate patients during colonoscopies without the need for a physician to monitor delivery of the injectable sedating agent, ...
Read more
(Reuters) - Health officials in India have revoked Johnson & Johnson's license to make cosmetics at a plant outside Mumbai after they discovered the company had used an unauthorized process ...
Read more
April 22, 2013 1:09 am by Berkrot, Bill | 1 Comments
In the past week, medical testing companies, such as Quest Diagnostics, medical device makers Johnson & Johnson and Abbott Laboratories, hospital operators, such as HCA Holdings Inc, and even diaper ...
Read more
April 17, 2013 4:44 am by Sell, David | 0 Comments
Though its Fort Washington plant is still being repaired, and overall profit fell 10.6 percent to $3.5 billion in the first quarter of 2013, Johnson & Johnson said Tuesday that ...
Read more
April 16 (Reuters) - An Illinois jury on Tuesday found in favor of Johnson & Johnson's DePuy unit in a product liability lawsuit involving the company's ASR hip implant, J&J ...
Read more
(Reuters) - Johnson & Johnson reported better-than-expected first-quarter earnings, as growth of newer medicines for cancer, hepatitis C and blood clots offset declining sales of its treatments for heartburn and ...
Read more
(Reuters) - Johnson & Johnson is recalling and replacing more than 2 million meters used to measure blood glucose levels in diabetics due to a failure to operate properly at ...
Read more
(Reuters) - A Los Angeles jury on Friday ordered Johnson & Johnson's DePuy orthopedic unit to pay more than $8 million in damages to a retired Montana prison guard who ...
Read more
March 1, 2013 11:12 am by Sell, David | 2 Comments
A jury in Atlantic City ordered Johnson & Johnson on Thursday to pay $7.8 million in punitive damages to a former hospice nurse for the pain and suffering she endured ...
Read more
(Reuters) - A New Jersey jury on Thursday ordered Johnson & Johnson to pay $7.76 million in punitive damages to a South Dakota nurse who claimed harm from the company's ...
Read more
